Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
---|---|---|---|---|---|---|
Filed 2021-06-16 13:20 Tx date 2021-06-15 |
$RP
RepliCel Life Sciences Inc. |
Hoffmann, Rolf
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$30,000
+75,000 vol $0.40 each |
225,000 | |
Filed 2020-12-01 12:09 Tx date 2020-11-30 |
$RP
RepliCel Life Sciences Inc. |
Hoffmann, Rolf
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-3,386.46
-16,126 vol $0.21 each |
489,572 | |
Filed 2020-12-01 12:09 Tx date 2020-10-26 |
$RP
RepliCel Life Sciences Inc. |
Hoffmann, Rolf
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-2,250
-15,000 vol $0.15 each |
505,698 | |
Filed 2019-01-18 Tx date 2017-07-31 |
$RP
RepliCel Life Sciences Inc. |
Hoffmann, Rolf
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
-35,000 vol |
75,000 | |
Filed 2019-01-18 Tx date 2016-08-10 |
$RP
RepliCel Life Sciences Inc. |
Hoffmann, Rolf
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
37 - Stock split or consolidation
|
-280,161 vol |
31,129 | |
Filed 2019-01-18 Tx date 2017-04-10 |
$RP
RepliCel Life Sciences Inc. |
Hoffmann, Rolf
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
55 - Expiration of warrants
|
-16,129 vol |
15,000 | |
Filed 2019-01-18 Tx date 2016-08-10 |
$RP
RepliCel Life Sciences Inc. |
Hoffmann, Rolf
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-315,000 vol |
35,000 | |
Filed 2019-01-18 Tx date 2016-08-10 |
$RP
RepliCel Life Sciences Inc. |
Hoffmann, Rolf
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
37 - Stock split or consolidation
|
-4,686,280 vol |
520,698 | |
Filed 2019-01-18 Tx date 2016-12-07 |
$RP
RepliCel Life Sciences Inc. |
Hoffmann, Rolf
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+75,000 vol |
110,000 | |
Filed 2018-08-07 Tx date 2018-07-30 |
$RP
RepliCel Life Sciences Inc. |
Hoffmann, Rolf
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$32,250
+75,000 vol $0.43 each |
425,000 | |
Filed 2015-06-30 Tx date 2013-04-10 |
$RP
RepliCel Life Sciences Inc. |
Hoffmann, Rolf
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
53 - Grant of warrants
|
+161,290 vol |
||
Filed 2015-06-30 Tx date 2013-04-10 |
$RP
RepliCel Life Sciences Inc. |
Hoffmann, Rolf
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
53 - Grant of warrants
|
+161,290 vol |
161,290 | |
Filed 2015-06-30 Tx date 2013-04-10 |
$RP
RepliCel Life Sciences Inc. |
Hoffmann, Rolf
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
53 - Grant of warrants
|
+161,290 vol |
||
Filed 2015-06-29 Tx date 2015-06-25 |
$RP
RepliCel Life Sciences Inc. |
Hoffmann, Rolf
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$46,500
+150,000 vol $0.31 each |
5,206,978 | |
Filed 2015-06-29 Tx date 2015-06-25 |
$RP
RepliCel Life Sciences Inc. |
Hoffmann, Rolf
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
53 - Grant of warrants
|
$76,500
+150,000 vol $0.51 each |
311,290 | |
Filed 2015-05-12 Tx date 2013-04-10 |
$RP
RepliCel Life Sciences Inc. |
Hoffmann, Rolf
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
53 - Grant of warrants
|
+161,290 vol |
||
Filed 2015-05-12 Tx date 2013-04-10 |
$RP
RepliCel Life Sciences Inc. |
Hoffmann, Rolf
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
53 - Grant of warrants
|
$161.29
+161,290 vol $0.001 each |
||
Filed 2015-05-12 Tx date 2013-04-10 |
$RP
RepliCel Life Sciences Inc. |
Hoffmann, Rolf
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
53 - Grant of warrants
|
+161,290 vol |
161,290 | |
Filed 2015-05-12 Tx date 2015-04-10 |
$RP
RepliCel Life Sciences Inc. |
Hoffmann, Rolf
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
55 - Expiration of warrants
|
-161,290 vol |
||
Filed 2015-05-12 Tx date 2015-04-10 |
$RP
RepliCel Life Sciences Inc. |
Hoffmann, Rolf
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
55 - Expiration of warrants
|
-161,290 vol |
||
Filed 2015-05-12 Tx date 2010-12-22 |
$RP
RepliCel Life Sciences Inc. |
Hoffmann, Rolf
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2015-05-12 Tx date 2013-04-10 |
$RP
RepliCel Life Sciences Inc. |
Hoffmann, Rolf
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
53 - Grant of warrants
|
$161.29
+161,290 vol $0.001 each |